ARCHIVES

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

This article is from The Cancer Letter archive.

Vol. 38 No. 44 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

NCI says SELECT study is close to full enrollment.

April 23, 2004

AACR Selects Eight Finalists To Compete For $15 Million Grants Funded By Telethon.

December 5, 2008

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012